Navigation Links
BMP Sunstone Reports Third Quarter 2008 Financial Results
Date:11/10/2008

1,044 828

Prepaid Expenses and Other Current

Assets 5,971 2,444

Total Current Assets 77,717 43,389

Property and Equipment, net 22,925 745

Investment in Sunstone China Limited -- 33,126

Investment in Alliance BMP 15,093 --

Investments, at Cost 146 137

Other Assets 70,004 3,053

Intangible Assets, net of accumulated

amortization 44,938 473

Total Assets $230,823 $80,923

Liabilities and Stockholders' Equity

Current Liabilities:

Notes Payable $29,694 $117

Accounts Payable 24,116 8,784

Deferred Revenue 143 151

Due to Related Parties 3,461 --

Accrued Expenses 18,582 3,952

Total Current Liabilities 75,996 13,004

Long-term debt, net of debt discount -- 18,910

Deferred Taxes 10,802 --

Total Liabilities 86,798 31,914

Stockholders' Equity:

Common Stock, $.001 Par Value;

75,000,000 and 50,000,000 Shares

Authorized as of September 30, 2008

and December 31, 2007, respectively;

39,808,864 and 31,240,913 Shares

Issued and Outstanding as of

September 30, 2008 and December 31,

2007, respectively
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
4. BMP Sunstone Reports Second Quarter 2008 Financial Results
5. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
6. BMP Sunstone Announces Participation in September Investor Conference
7. BMP Sunstone Announces Participation in November Investor Conferences
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedtheapprovalofallofits,"firstday"motionsb...he"BankruptcyCourt").deCODElastweekfiledavoluntary...ankruptcyCodewiththe,BankruptcyCourt. , Theor...tinue,tooperateitsbusinessduringtheChapter11procee...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEne...blicDevelopmentAuthority(OPDA)wererecentlyawarded$...lizationBoard(CERB)inaprivate/publicpartnershiptoc...neryinLincolnCounty,WA. ,, "Thisinvestmentwills...bringover70greenjobstoLincolnCounty,"saidBlueMarbl...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--...tybiopharmaceuticalcompany,today,announcedthatitha...glucerasealfa,thecompany,senzymereplacementtherapy....Thisisthethirdmarketing,applicationforvelaglucera...sintheUnitedStatesandCanada. , Basedonaglobal...
(Date:11/24/2009)..., Program Connects Custom... Samples Collected with DNA Genotek Products , ...24, 2009 -- DNA Genotek , a leading provider of p...ation and preparation, today announced its new glo...t enhancements for DNA Genotek,s partner community...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ons has,long been used as a marketing tool by the ...bility to reach consumers has never been greater. ...joined the traditional press,release as effective ...his,understanding, new research was conducted by B...ns activities are most effective at educating,and ...
...ytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) announ...nterim results of a U.S. Phase II trial investigat...and soft tissue sarcomas metastatic to,the lung is...nstitute of,Drug Development (IDD), the Cancer The...s Health Science Center, (UTHSC), San Antonio, Tex...
...d its annual "Power of Partnership" award to Baxte...cal device and specialty pharmaceutical,company. B...ibution,Management Association,s (HDMA) Annual Lea...Power of Partnership" award was created by AmeriCa...d distribution organizations that have,shown excep...
Other Biology Technology:New Study Shares Best Practices in Biopharma Public Relations 2Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data 2Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data 3AmeriCares Presents 'Power of Partnership' Award to Baxter 2AmeriCares Presents 'Power of Partnership' Award to Baxter 3
(Date:11/26/2009)... Aureus ) and other drug-resistant bacteria could ...ype devices have been developed to offer safe, qui... Two prototype devices have been developed: one fo...ds and feet) in hospitals and public spaces where ...shoot bacteria-killing agents into infested chroni...
(Date:11/25/2009)...ers and ambulance workers faced a terrifying rescu...attled to save people from the collapsing Twin Tow...cuated as many people as they could in an area whi...g their jobs even harder was the problem of poor c...ves jammed mobile networks with calls and the emer...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 1Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 2Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 3Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 4Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 1Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 2Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 3Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 4Cornflakes White Bread Could Boost Heart Risk 48653 1Cornflakes White Bread Could Boost Heart Risk 48653 2Cornflakes White Bread Could Boost Heart Risk 48653 3
...ook For Biometrics Revenue and Profit Growth, WAL...Bulletin Board: BKYI), a leader in wireless public...solutions, today announced its,financial results f...tal revenue from continuing operations for the thr...n representing a 27% decrease from the,$3.0 millio...
...a. --- The observation that males evolve more quic...y biologist Charles Darwin noted the majesty of a ...ness of the peahens. , No matter the species, mal...elodious warbles in an eternal competition to win ...n. , Why males are in evolutionary overdrive even...
...s prepare to discuss conservation-friendly carbon ...s a new wave of deforestation in the South America...t Anglia and Brazils Goeldi Museum highlights once...n forest. , Working in the north-eastern Brazili...ertook the single-largest assessment of the biodiv...
Other Biology News:BIO-key Reports Third Quarter 2007 Results 2BIO-key Reports Third Quarter 2007 Results 3BIO-key Reports Third Quarter 2007 Results 4BIO-key Reports Third Quarter 2007 Results 5Simple reason helps males evolve more quickly 2Simple reason helps males evolve more quickly 3Single-largest biodiversity survey says primary rainforest is irreplaceable 2
Expansion and Cryopreservation of Cells from Meridian Life Science, Inc.
HandyStep manual repeating pipette from BrandTech Scientific
Zymo-Spin I-96 from Zymo Research
RT-PCR Grade Water from Ambion
Biology Products: